Beckman coulter INC:1110232 [24-000344]
Ended Awarded Last action
- Contract number
- 75N91024F00002
- Awardee
-
Beckman Coulter, Inc. UEI Z4DRFM3LMJB8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,142
Award facts
- Contract value 100% obligated
- $14,142.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Beckman Coulter, Inc. received a $14,142.00 firm fixed-price call order under a Blanket Purchase Agreement (BPA) from the National Cancer Institute (NCI), a component of the National Institutes of Health. The award, issued on December 23, 2023, with an ultimate completion date of December 22, 2024, represents a delivery order against an existing BPA vehicle. The work will be performed at the NCI's Bethesda, Maryland facility. This contract was not designated as a set-aside and reflects Beckman Coulter's status as a preferred vendor for specialized scientific equipment and services supporting federal biomedical research initiatives.
Beckman Coulter, through its US Customer Operations Division, is a leading supplier of biomedical testing equipment, laboratory instruments, reagents, and maintenance services to federal agencies. The company's expertise encompasses flow cytometry systems, liquid handling equipment, centrifugation devices, and related calibration and technical support services. This BPA call order supports the NCI's research and diagnostic capabilities, consistent with the company's broader contract portfolio across multiple NIH institutes, the Department of Veterans Affairs, Centers for Disease Control and Prevention, Department of Defense, and other federal research organizations. Beckman Coulter maintains multiple significant IDCs and BPAs across federal agencies, ranging from $2 million to $10 million, enabling flexible procurement of specialized laboratory equipment and maintenance services through task orders and delivery orders extending through 2029.
Quick answers
Who was awarded contract 75N91024F00002?
75N91024F00002 was awarded to Beckman Coulter, Inc. by National Cancer Institute (National Institutes of Health) on December 23, 2023.
How much is contract 75N91024F00002 worth?
The government has obligated $14,142 on 75N91024F00002.
Is contract 75N91024F00002 an order under another contract?
Yes. 75N91024F00002 is a BPA call under HHSN263201600014B, a blanket purchase agreement.
Was contract 75N91024F00002 competed?
The extent of competition for 75N91024F00002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award